Purchase Order 75N91025P00116

Award Date 1/12/25
Potential Completion Date 1/11/26
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.), a for-profit manufacturer of medical imaging products and services. The $18,663 contract is for a maintenance agreement with a period of performance from March 1, 2025 to February 28, 2026. The contract does not have a set-aside designation. Revvity...
This firm-fixed-price purchase order contract was awarded by the National Cancer Institute, part of the National Institutes of Health, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.). The contract, valued at $365,598.51, is to provide a service protection plan to ensure that critical research instruments are always available and in good working condition for the agency's research staff. The contract has a completion date of November 29, 2024, and does not include any...
This is a firm fixed-price purchase order issued by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for the service and maintenance of a PerkinElmer Ensight System. The contract has a ceiling value of $21,975.00 and a period of performance through December 31, 2025. This award is not associated with a set-aside program. Revvity Health Sciences is a for-profit...
This federal contract award, valued at $171,985.25, was issued by the National Cancer Institute (NCI) to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for the provision of a MANTRA Quantitative Pathology Imaging System. The contract is a firm fixed-price purchase order with a period of performance ending on March 4, 2016. Revvity Health Sciences is a for-profit manufacturer of medical imaging products and services that has received multiple prime contract awards and...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. (doing business as PerkinElmer, Inc.). The contract is for the renewal of Revvity's service contract and has a total ceiling value of $11,494.08. The contract does not have a set-aside designation and will run through January 31, 2026. Revvity Health Sciences...
This federal contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.). The contract, valued at $178,361.58, is for the maintenance and service of high-throughput microscopy, automated image plate loading/unloading, and liquid handling equipment. This is a firm fixed-price purchase order contract with a period of performance from August 2015 to August 2016. The...
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences, a civilian agency, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.), for crating, packing, unpacking, and re-installing the Revvity Opera Phenix. The total ceiling value of the contract is $20,281.50, and the ultimate completion date is January 31, 2025. There is no set-aside designation for this award. Revvity Health Sciences, Inc. is a for-profit manufacturer that...
This federal contract award was made by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.). The $10,627.20 firm fixed-price purchase order is for the delivery of unspecified medical imaging products and services. The contract does not have a set-aside designation. Revvity Health Sciences is a for-profit manufacturer that has a history...
This is a purchase order awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to Revvity Health Sciences, Inc., doing business as PerkinElmer Inc., for $5,771.86. The order is for unspecified medical imaging products and services, based on the company's history of providing laboratory equipment, automation applications, and maintenance services to federal agencies. This award is not associated with a set-aside program. Revvity Health...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on September 5, 2014. The $6,994.00 contract does not have a set-aside designation and was for the delivery of unspecified medical imaging products and services to support NIAID research activities in Bethesda, Maryland. Revvity Health Sciences is a subsidiary of the parent company Revvity Inc., which provides...

This is a $18,290 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.). The service agreement has an ultimate completion date of January 11, 2026. Revvity Health Sciences is a for-profit organization that manufactures medical imaging products and equipment. The company has previously received prime contracts, subcontracts, and indefinite delivery vehicle awards from federal agencies like the NIH, CDC, DoD, and VA to provide a range of laboratory instrumentation and related maintenance services. This award does not utilize a set-aside designation.

Generated 12/7/24, 9:25 AM